Managers / Q1 2021 · view latest →
APIS CAPITAL ADVISORS, LLC
CIK 0001386892 · 110 E 42ND STREET, SUITE 1419, NEW YORK, NY, 10017 · (203) 409-6307
Reported Value
$110M
Q1 2021
Positions
43
Filings on Record
26
2019–present window
Filed
May 14, 2021
original filing
Summary
Apis Capital Advisors, LLC reported $110M in U.S.-listed holdings across 43 positions for Q1 2021.
Its largest position, DAR, represents 13.1% of the portfolio.
Compared with Q4 2020, the fund opened 16 new positions and exited 11.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 73.8% · $81M
- ADR · 14.8% · $16M
- Other · 11.4% · $13M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TFF PHARMACEUTICALS INC | NEW | +182.5K | 182.5K | +$2M | $2M |
| AMARIN CORP PLC | NEW | +270.0K | 270.0K | +$2M | $2M |
| OPRXOPTIMIZERX CORP | NEW | +30.0K | 30.0K | +$1M | $1M |
| FLLFULL HSE RESORTS INC | NEW | +142.3K | 142.3K | +$1M | $1M |
| HECUSDHUDSON EXECUTIVE INVT CORP | NEW | +110.0K | 110.0K | +$1M | $1M |
| AXTIAXT INC | NEW | +80.0K | 80.0K | +$933,000 | $933,000 |
| GORES HOLDINGS VI INC | NEW | +60.0K | 60.0K | +$822,000 | $822,000 |
| 4XC1KALVISTA PHARMACEUTICALS INC | NEW | +30.0K | 30.0K | +$771,000 | $771,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2021
43 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | DARDARLING INGREDIENTS INC | COM | 13.10% | $14M | 196.0K |
| 2 | INTELLIGENT SYS CORP NEW | COM | 9.22% | $10M | 248.0K |
| 3 | NCSUSDCORNERSTONE BLDG BRANDS INC | COM | 8.21% | $9M | 644.0K |
| 4 | SIMOSILICON MOTION TECHNOLOGY CO | SPONSORED ADR | 7.28% | $8M | 135.0K |
| 5 | LPROOPEN LENDING CORP | COM CL A | 5.15% | $6M | 160.0K |
| 6 | DMY TECHNOLOGY GROUP INC II | COM CL A | 4.56% | $5M | 341.1K |
| 7 | MXMAGNACHIP SEMICONDUCTOR CORP | COM | 4.05% | $4M | 179.0K |
| 8 | G7AGRUPO AEROPORTUARIO DEL CENT | SPON ADR | 3.39% | $4M | 73.8K |
| 9 | ELASTIC N V | ORD SHS | 3.23% | $4M | 32.0K |
| 10 | PENN VA CORP | COM | 2.84% | $3M | 233.5K |
| 11 | ORION ENGINEERED CARBONS S A | COM | 2.69% | $3M | 150.0K |
| 12 | MVBFMVB FINL CORP | COM | 2.61% | $3M | 85.0K |
| 13 | BETTERWARE DE MXC S A B DE C | SHS NEW | 2.36% | $3M | 67.0K |
| 14 | XPELXPEL INC | COM | 2.31% | $3M | 49.0K |
| 15 | TFF PHARMACEUTICALS INC | COM | 2.25% | $2M | 182.5K |
| 16 | IESCIES HLDGS INC | COM | 2.11% | $2M | 46.0K |
| 17 | GD8AGRAVITY CO LTD | SPONSORED ADS NE | 1.76% | $2M | 16.8K |
| 18 | RSIRUSH STREET INTERACTIVE INC | COM | 1.63% | $2M | 110.0K |
| 19 | ASRGRUPO AEROPORTUARIO DEL SURE | SPON ADR SER B | 1.62% | $2M | 10.0K |
| 20 | VICRVICOR CORP | COM | 1.55% | $2M | 20.0K |
| 21 | AMARIN CORP PLC | SPONS ADR NEW | 1.52% | $2M | 270.0K |
| 22 | BTAIEURBIOXCEL THERAPEUTICS INC | COM | 1.41% | $2M | 36.0K |
| 23 | OPRXOPTIMIZERX CORP | COM NEW | 1.33% | $1M | 30.0K |
| 24 | IDNINTELLICHECK INC | COM NEW | 1.17% | $1M | 153.7K |
| 25 | VSTOEURVISTA OUTDOOR INC | COM | 1.17% | $1M | 40.0K |
| 26 | FLLFULL HSE RESORTS INC | COM | 1.10% | $1M | 142.3K |
| 27 | GTXIEURONCTERNAL THERAPEUTICS INC | COM | 1.09% | $1M | 144.0K |
| 28 | HECUSDHUDSON EXECUTIVE INVT CORP | COM CL A | 0.99% | $1M | 110.0K |
| 29 | AXTIAXT INC | COM | 0.85% | $933,000 | 80.0K |
| 30 | CURIS INC | COM NEW | 0.82% | $906,000 | 80.0K |
| 31 | OPNTEUROPIANT PHARMACEUTICALS INC | COM | 0.77% | $850,000 | 80.0K |
| 32 | GORES HOLDINGS VI INC | COM CL A | 0.75% | $822,000 | 60.0K |
| 33 | CYBE1EURCYBEROPTICS CORP | COM | 0.71% | $779,000 | 30.0K |
| 34 | 4XC1KALVISTA PHARMACEUTICALS INC | COM | 0.70% | $771,000 | 30.0K |
| 35 | PUMPPROPETRO HLDG CORP | COM | 0.68% | $746,000 | 70.0K |
| 36 | CYMABAY THERAPEUTICS INC | COM | 0.50% | $545,000 | 120.0K |
| 37 | ACTGACACIA RESH CORP | ACACIA TCH COM | 0.48% | $532,000 | 80.0K |
| 38 | MYOMYOMO INC | COM NEW | 0.47% | $512,000 | 40.0K |
| 39 | DAIODATA I O CORP | COM | 0.41% | $453,000 | 83.5K |
| 40 | LBPSGBP4D PHARMA PLC | SPONSORED ADS | 0.40% | $445,000 | 37.7K |
| 41 | GSXGBPGSX TECHEDU INC | SPONSORED ADS | 0.36% | $398,000 | 11.8K |
| 42 | LXULSB INDS INC | COM | 0.23% | $257,000 | 50.0K |
| 43 | MNTKMONTAUK RENEWABLES INC | COM | 0.20% | $217,000 | 18.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $648M | 52 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $574M | 43 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $453M | 49 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $282M | 42 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $207M | 42 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $150M | 29 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $144M | 33 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $136M | 36 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $132M | 36 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $95M | 27 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $77M | 23 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $99M | 30 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $94M | 24 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $86M | 27 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $67M | 25 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $89M | 29 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $83M | 30 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $90M | 22 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $105M | 37 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $116M | 36 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $110M | 43 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $103M | 38 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $64M | 27 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $67M | 31 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $83M | 31 | May 7, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $75M | 26 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.